SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-002398
Filing Date
2022-01-27
Accepted
2022-01-27 16:15:39
Documents
12
Period of Report
2022-01-25
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 32898
  Complete submission text file 0001493152-22-002398.txt   207399

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ghsi-20220125.xsd EX-101.SCH 3043
3 XBRL LABEL FILE ghsi-20220125_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE ghsi-20220125_pre.xml EX-101.PRE 22371
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3728
Mailing Address 2925 RICHMOND AVENUE SUITE 1200 HOUSTON TX 77098
Business Address 2925 RICHMOND AVENUE SUITE 1200 HOUSTON TX 77098 (800) 873-5141
Guardion Health Sciences, Inc. (Filer) CIK: 0001642375 (see all company filings)

IRS No.: 474428421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38861 | Film No.: 22563332
SIC: 2834 Pharmaceutical Preparations